Résumé
BACKGROUND: The optimal method of providing transfusion medicine (TM) education has not been determined. Transfusion Camp was established in 2012 at the University of Toronto as a centrally delivered TM education program for postgraduate trainees. The impact of Transfusion Camp on knowledge, attitudes, and self-reported behavior was evaluated. METHODS: Didactic lectures (delivered locally, by webinar, or recorded) and locally facilitated team-based learning seminars were delivered over 5 days during the academic year to 8 sites: 7 in Canada and 1 in the United Kingdom. Knowledge assessment using a validated 20-question multiple-choice exam was conducted before and after Transfusion Camp. Attitudes and self-reported behavior were collected through a survey. RESULTS: Over 2 academic years (July 2016 to June 2018), 390 trainees from 16 different specialties (predominantly anesthesia, 41%; hematology, 14%; and critical care, 7%) attended at least 1 day of Transfusion Camp. The mean pretest score was 10.3 of 20 (±2.9; n = 286) compared with posttest score of 13.0 (±2.8; n = 194; p < 0.0001). Lower pretest score and greater attendance (4–5 days compared with 1–3 days) were associated with larger improvement in posttest score; delivery format, specialty, and postgraduate year were not. Trainees reported an improvement in self-rated abilities to manage TM scenarios; 95% rated TM knowledge as very or extremely important in providing patient care; and 81% indicated that they had applied learning from Transfusion Camp into clinical practice. CONCLUSIONS: Transfusion Camp increased TM knowledge, fostered a positive attitude toward TM, and enabled a self-reported positive impact on transfusion practice in postgraduate trainees. It is a novel and scalable approach to delivering TM education.
Langue d'origine | English |
---|---|
Pages (de-à) | 2141-2149 |
Nombre de pages | 9 |
Journal | Transfusion |
Volume | 59 |
Numéro de publication | 6 |
DOI | |
Statut de publication | Published - juin 2019 |
Note bibliographique
Funding Information:YL has received research support from Novartis and Octapharma, consulting fees from Amgen, and Pfizer. AA is a consultant for Medtronic and Zoll. KP has received honoraria from Alexion and Shire and consulting fees from Ablynx, Alexion and Shire. JC has received research funding from Octapharma and Canadian Blood services. All other authors have no conflicts of interest to declare.
Funding Information:
Financial support for the University of Toronto site was provided by the Ontario Regional Blood Coordinating Network, the University of Toronto Department of Laboratory Medicine and Pathobiology and in 2016–2017, partially by two unrestricted educational grants from CSL Behring and Grifols. Financial support for the University of British Columbia site in 2017–2018 was provided by the British Columbia Provincial Blood Coordinating Office, the UBC
Funding Information:
We thank the postgraduate trainees and faculty who participated in Transfusion Camp. We acknowledge Dr. Matthew Yan for assistance with Rasch analysis, Dr. Shuoyan Ning for her contributions to the program director survey, and the following local Transfusion Camp site administrative leads and collaborators: Dr. Alan Tinmouth, Alycia-Anne Martin, Tyra Young (University of Ottawa), Heidi Devlin (Dalhousie University), Elena Bidochka, Gina Furlong (McMaster University), Shelley Cox (Queen's University), Dr. Ed Conway, Hana Kim, Amarpreet Grewal, Mira Multinovic (University of British Columbia), Deb Quirion, Krystyna Schornagel, Chelsea Malkowich (University of Saskatchewan), Mattina Kranenburg (Western University) in Canada, and June Smith (Oxford University) in the United Kingdom. We thank Julie Sarwan and Miriam Strzinar for their local administrative support, and Robert Danielsen for audiovisual support at St. Michael's Hospital for the University of Toronto Transfusion Camp. We acknowledge Chantal Armali and Attiya Waqqas for assistance with data compilation from the University of Toronto QUEST Research Program.
Funding Information:
Centre for Blood Research and grants from Grifols, Octapharma and Bayer. Received for publication December 17, 2018; revision received January 25, 2019, and accepted February 9, 2019. doi:10.1111/trf.15284 © 2019 AABB TRANSFUSION 2019;59;2141–2149
Publisher Copyright:
© 2019 AABB
ASJC Scopus Subject Areas
- Immunology and Allergy
- Immunology
- Hematology